Financial results for the second quarter of 2025 unveiled by Performant Healthcare, Inc.
Performant Healthcare Announces Preliminary Q2 2025 Financial Results and Pending Acquisition by Machinify
Performant Healthcare, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, has announced preliminary financial results for Q2 2025. The company expects to report revenues of approximately $37.8 million, net income of around $2.1 million, and adjusted EBITDA near $6.2 million.
This preliminary announcement was made on August 1, 2025, ahead of the Form 10-Q filing due on August 7, 2025. The announcement coincides with Performant's pending acquisition by Machinify, a deal expected to close by the end of 2025. The acquisition transaction values Performant at approximately $670 million and will result in the delisting of its shares from Nasdaq.
The company has entered into a definitive agreement to be acquired by Machinify. As a result, Performant will no longer hold its second quarter results conference call originally scheduled for August 5, 2025.
Performant works with leading national and regional healthcare payers to provide eligibility-based and claims-based services. The company also supports healthcare payers in identifying, preventing, and recovering waste and improper payments.
Depreciation and amortization for the three months ended June 30, 2025, was $1,467. Net income for the same period was $2,078, and provision for income taxes was $360. Interest expense, net for the same period, was $202.
Stock-based compensation for the three months ended June 30, 2025, was $2,066. Performant has provided a reconciliation of Non-GAAP results for the same period, with Adjusted EBITDA of $6,173.
The press release contains forward-looking statements regarding the company's outlook for revenues, net income (loss), and adjusted EBITDA in 2025 and beyond. However, actual results may differ materially due to various factors, including the company's ability to generate revenue following long implementation periods associated with new customer contracts, client relationships, commercial client growth strategy, many customer contracts being subject to periodic renewal, not being exclusive, and not providing for committed business volumes.
Investors seeking more information can contact Jon Bozzuto, the contact for investor relations at Performant Healthcare, Inc. His contact information is (925) 960-4988 and [email protected].
Performant Healthcare, Inc. expects to file its Form 10-Q for the second quarter of 2025 on August 7, 2025. The company is withdrawing its previously issued full-year 2025 guidance.
The acquisition by Machinify presents an exciting opportunity for Performant to continue its growth and service to the healthcare industry. More details about the acquisition will be shared as they become available.
- Performant Healthcare anticipates reporting a preliminary Q2 2025 revenue of approximately $37.8 million, with a net income of around $2.1 million and adjusted EBITDA near $6.2 million.
- The upcoming acquisition by Machinify, valued at approximately $670 million, has prompted Performant to forgo its second quarter results conference call, originally scheduled for August 5, 2025.
- In the news, Performant Healthcare, a leading provider of healthcare payment integrity services, has announced plans to be acquired by Machinify, with the deal expected to close by the end of 2025 and result in the delisting of Performant's shares from Nasdaq.
- The pending acquisition by Machinify offers an exciting prospect for Performant Healthcare's continued growth and service within the healthcare industry, with more details to be shared as they become available.
